Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren

Trends in Molecular Medicine

Volumn 13, Issue 5, 2007, Pages 210-217

  Bandhuvula, Padmavathi ^a   Saba, Julie D ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DAUNORUBICIN; ETOPOSIDE; FINGOLIMOD; LYASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE LYASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; AUTOIMMUNE DISEASE; CANCER; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RESISTANCE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOPROPHYLAXIS; DRUG MECHANISM; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME STRUCTURE; HISTOCOMPATIBILITY; HUMAN; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; ISCHEMIC PRECONDITIONING; LYMPHOCYTE TRANSFER; NONHUMAN; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; TISSUE DISTRIBUTION;

ALDEHYDE-LYASES; ANIMALS; APOPTOSIS; GROWTH AND DEVELOPMENT; HUMANS; IMMUNITY; INFLAMMATION; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

SIREN;

EID: 34247617182     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2007.03.005     Document Type: Review

References (89)

1. Gardell S.E., et al. Emerging medicinal roles for lysophospholipid signaling. Trends Mol. Med. 12 (2006) 65-75
2. Karliner J.S. Mechanisms of cardioprotection by lysophospholipids. J. Cell. Biochem. 92 (2004) 1095-1103
3. Milstien S., and Spiegel S. Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. Cancer Cell 9 (2006) 148-150
4. McVerry B.J., and Garcia J. In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell. Signal. 17 (2005) 131-139
5. Oskouian B., and Saba J.D. Death and taxis: what non-mammalian models tell us about sphingosine-1-phosphate. Semin. Cell Dev. Biol. 15 (2004) 529-540
6. Sanchez T., and Hla T. Structural and functional characteristics of S1P receptors. J. Cell. Biochem. 92 (2004) 913-922
7. Rosen H. Chemical approaches to the lysophospholipid receptors. Prostaglandins Other Lipid Mediat. 77 (2005) 179-184
8. Kono M., et al. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J. Biol. Chem. 279 (2004) 29367-29373
9. Cyster J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23 (2005) 127-159
10. Taha T.A., et al. Sphingosine kinase: biochemical and cellular regulation and role in disease. J. Biochem. Mol. Biol. 39 (2006) 113-131
11. Brindley D.N. Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer. J. Cell. Biochem. 92 (2004) 900-912
12. Pyne S., et al. Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases. Semin. Cell Dev. Biol. 15 (2004) 491-501
13. Giussani P., et al. Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of ceramide. Mol. Cell. Biol. 26 (2006) 5055-5069
14. Mechtcheriakova D., et al. Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell. Signal. 19 (2006) 748-760
15. Van Veldhoven P.P. Sphingosine-1-phosphate lyase. In: Merrill Jr. A.H., and Hannun Y.A. (Eds). Sphingolipid Metabolism and Cell Signaling Part A (2000), Academic Press 244-254
16. Schwab S.R., et al. Lymphocyte sequestration through S1P lyase inhibition an disruption of S1P gradients. Science 309 (2005) 1735-1739
17. Oskouian B., et al. Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is downregulated in colon cancer. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 17384-17389
18. Zhang, K. et al. (2007) Redirection of sphingolipid metabolism towards de novo synthesis of ethanolamine in Leishmania EMBO J. 26, 1094-1104
19. Ogretmen B., and Hannun Y.A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 4 (2004) 604-616
20. Bandhuvula P., et al. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J. Biol. Chem. 280 (2005) 33697-33700
21. Triola G., et al. Specificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]o ctanamide (GT11) in primary cultured cerebellar neurons. Mol. Pharmacol. 66 (2004) 1671-1678
22. Horibata Y., and Hirabayashi Y. Identification and characterization of a human ethanolaminephosphotransferase1 (hEPT1). J. Lipid Res. 48 (2006) 503-508
23. Dobrosotskaya I.Y., et al. Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila. Science 296 (2002) 879-883
24. Saba J.D., et al. The BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase. J. Biol. Chem. 272 (1997) 26087-26090
25. Zhou J., and Saba J. Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast. Biochem. Biophys. Res. Commun. 242 (1998) 502-507
26. Van Veldhoven P.P., et al. Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22. Biochim. Biophys. Acta 1487 (2000) 128-134
27. Herr D.R., et al. Sply regulation of sphingolipid signaling molecules is essential for Drosophila development. Development 130 (2003) 2443-2453
28. Mendel J., et al. Sphingosine phosphate lyase expression is essential for normal development in Caenorhabditis elegans. J. Biol. Chem. 278 (2003) 22341-22349
29. Li G., et al. Sphingosine-1-phosphate lyase has a central role in the development of Dictyostelium discoideum. Development 128 (2001) 3473-3483
30. Stoffel W., et al. Distribution and properties of dihydrosphingosine-1-phosphate aldolase (sphinganine-1-phosphate alkanal-lyase). Hoppe Seylers Z. Physiol. Chem. 350 (1969) 1233-1241
31. Van Veldhoven P.P., and Mannaerts G.P. Subcellular localization and membrane topology of sphingosine-1-phosphate lyase in rat liver. J. Biol. Chem. 266 (1991) 12502-12507
32. Reiss U., et al. Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis. J. Biol. Chem. 279 (2004) 1281-1290
33. Ikeda M., et al. Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5′-phosphate binding domain exposed to the cytosol. Biochem. Biophys. Res. Commun. 325 (2004) 338-343
34. Kohno M., et al. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell. Biol. 26 (2006) 7211-7223
35. Genter M.B., et al. Microarray-based discovery of highly expressed olfactory mucosal genes: potential roles in the various functions of the olfactory system. Physiol. Genomics 16 (2003) 67-81
36. Yatomi Y., et al. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. J. Biol. Chem. 272 (1997) 5291-5297
37. Genter M.B. Molecular biology of the nasal airways: how do we assess cellular and molecular responses in the nose?. Toxicol. Pathol. 34 (2006) 274-280
38. Vesper H., et al. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J. Nutr. 129 (1999) 1239-1250
39. Cliffe L.J., et al. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 308 (2005) 1463-1465
40. Radtke F., and Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 307 (2005) 1904-1909
41. Renault A.D., et al. Metabolism of sphingosine 1-phosphate and lysophosphatidic acid: a genome wide analysis of gene expression in Drosophila. Mech. Dev. 119 Suppl. 1 (2002) S293-S301
42. Kihara A., et al. Sphingosine-1-phosphate lyase is involved in the differentiation of F9 embryonal carcinoma cells to primitive endoderm. J. Biol. Chem. 278 (2003) 14578-14585
43. Maduro M.F., and Rothman J.H. Making worm guts: the gene regulatory network of the Caenorhabditis elegans endoderm. Dev. Biol. 246 (2002) 68-85
44. Molkentin J.D. The zinc finger-containing transcription factors GATA-4, -5, and -6. J. Biol. Chem. 275 (2000) 38949-38952
45. Oskouian B., et al. Regulation of sphingosine-1-phosphate lyase gene expression by members of the GATA family of transcription factors. J. Biol. Chem. 280 (2005) 18403-18410
46. Chen W.V., et al. Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nat. Genet. 36 (2004) 304-312
47. Alvarez R.H., et al. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin. Proc. 81 (2006) 1241-1257
48. Schmahl J., et al. PDGF signaling specificity is mediated through multiple immediate early genes. Nat. Genet. 39 (2006) 52-60
49. Olivera A., and Spiegel S. Sphingosine 1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365 (1993) 557-559
50. Hobson J.P., et al. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291 (2001) 1800-1803
51. Hutton J.J., et al. Microarray and comparative genomic-based identification of genes and gene regulatory regions of the mouse immune system. BMC Genomics 5 (2004) 82
52. Dannenberg J.H., et al. mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev. 19 (2005) 1581-1595
53. Zhan X., and Desiderio D.M. Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry. Anal. Biochem. 354 (2006) 279-289
54. Huang H., et al. KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites. Nucleic Acids Res. 33 (2005) W226-W229
55. Kariya Y., et al. Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis. Genes Cells 10 (2005) 605-615
56. Kume H., and Sasaki H. Ethanolamine modulates DNA synthesis through epidermal growth factor receptor in rat primary hepatocytes. In Vitro Cell. Dev. Biol. Anim. 42 (2006) 20-26
57. Crilly K.S., et al. Promitogenic effects of ethanol, methanol, and ethanolamine in insulin-treated fibroblasts. Biochem. Pharmacol. 60 (2000) 1391-1398
58. Liu Y., et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106 (2000) 951-961
59. Jacoby R., et al. Del(10)(q22.3q24. 1) associated with juvenile polyposis. Am. J. Med. Genet. 70 (1997) 361-364
60. Li G., et al. Molecular basis for resistance to the anticancer drug cisplatin in Dictyostelium. Microbiology 146 (2000) 2219-2227
61. Min J., et al. Overexpression of sphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum-based chemotherapy drugs. Eukaryot. Cell 3 (2004) 795-805
62. Min J., et al. Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. Mol. Cancer Res. 3 (2005) 287-296
63. Visentin B., et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9 (2006) 225-238
64. Ramaswamy S., et al. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33 (2003) 49-54
65. Hibbs K., et al. Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am. J. Pathol. 165 (2004) 397-414
66. Hong G., et al. Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells. FEBS Lett. 460 (1999) 513-518
67. Xu Y., et al. The role and clinical applications of bioactive lysolipids in ovarian cancer. J. Soc. Gynecol. Investig. 8 (2001) 1-13
68. Paris F., et al. Sphingosine-1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat. Med. 8 (2002) 901-902
69. Morita Y., and Tilly J.L. Sphingolipid regulation of female gonadal cell apoptosis. Ann. N. Y. Acad. Sci. 905 (2000) 209-220
70. Tilly J.L., and Kolesnick R.N. Sphingolipid signaling in gonadal development and function. Chem. Phys. Lipids 102 (1999) 149-155
71. Tilly J.L., and Kolesnick R. Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim. Biophys. Acta 1585 (2002) 135-138
72. Graler M.H., and Goetzl E.J. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophys. Acta 1582 (2002) 168-174
73. Pettus B.J., et al. The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate. Mol. Pharmacol. 68 (2005) 330-335
74. Chiba K., et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. J. Immunol. 160 (1998) 5037-5044
75. Brinkmann V., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277 (2002) 21453-21457
76. Mandala S., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296 (2002) 346-349
77. Webb M., et al. Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J. Neuroimmunol. 153 (2004) 108-121
78. Chiba K., et al. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate. Transplant. Proc. 37 (2005) 102-106
79. Sanchez T., et al. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J. Biol. Chem. 278 (2003) 47281-47290
80. Graler M.H., and Goetzl E.J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors. FASEB J. 18 (2004) 551-553
81. Matloubian M., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (2004) 355-360
82. Chi H., and Flavell R. Regulation of T cell trafficking and primary immune responses by sphingosine 1-phosphate receptor 1. J. Immunol. 174 (2005) 2485-2488
83. Ley K., and Morris M. Signals for lymphocyte egress. Nat. Immunol. 6 (2005) 1215-1216
84. Pinschewer D.D., et al. FTY720 immunosuppression impairs effector T-cell peripheral homing without affecting induction, expansion and memory. J. Immunol. 164 (2000) 5761-5770
85. Zhi L., et al. Sphingosine kinase 1 regulates pro-inflammatory responses triggered by TNFα in primary human monocytes. J. Cell. Physiol. 208 (2006) 109-115
86. Pettus B.J., et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-α. FASEB J. 17 (2003) 1411-1421
87. Michaud J., et al. Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Lett. 580 (2006) 4607-4612
88. Seo E.Y., et al. Identification of the target genes of atopic dermatitis by real-time PCR. J. Invest. Dermatol. 126 (2006) 1187-1189
89. Holleran W.M., et al. Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett. 580 (2006) 5456-5466